When the data from the 82 patients with stage IV melanoma were fitted into a Cox proportional hazard model that included the APC/CTNNB1 mutation status and the mutation burden as covariates, the APC/CTNNB1 mutation status coefficient remained significant (p = 0.0245). This evidence concerns the gene CTNNB1 and melanoma.